View Exam | PowerPak

1. ) What percentage of the ~40,000 total new HIV infection diagnoses in 2015 occurred in persons aged 50 and older?

A. ) 4% B. ) 11% C. ) 17% D. ) 36% E. ) Unsure

2. ) Which of the following antiretroviral treatment regimens is considered to be a “Recommended Initial Regimen for Most People with HIV” by the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents?

A. ) Darunavir/cobicistat plus tenofovir/emtricitabine B. ) Dolutegravir plus tenofovir/emtricitabine C. ) Rilpivarine/tenofovir/emtricitabine D. ) Unsure

3. ) A person is newly-diagnosed with HIV infection. He is determined to be POSITIVE for the HLA-B*5701 major histocompatibility complex (MHC) class I allele. Which of the following antiretrovirals should NOT be administered to the patient?

A. ) Abacavir B. ) Atazanavir C. ) Dolutegravir D. ) Lamivudine E. ) Unsure

4. ) TRUE or FALSE: Tenofovir alafenamide should be used instead of tenofovir disoproxil in a patient with a medical comorbidity history that includes osteoporosis.

A. ) True B. ) False C. ) Unsure

5. ) Which of the following antiretrovirals would have the LOWEST risk of having CYP450-mediated drug-drug interactions?

A. ) Atazanavir B. ) Efavirenz C. ) Darunavir D. ) Emtricitabine E. ) Unsure

6. ) With regard to adherence to the continuum of HIV care, what percentage of patients living with HIV are retained in HIV medical care?

A. ) 24% B. ) 57% C. ) 75% D. ) 91%

7. ) Which of the following roles could a Pharmacist readily perform in any practice setting as part of a multidisciplinary care team for persons living with HIV?

A. ) Encouraging HIV testing B. ) Monitoring for adherence to antiretroviral therapy C. ) Screening for drug-drug and drug-disease state interactions D. ) Roles B & C E. ) All of the above roles

Evaluation Questions

8. How confident are you in your treatment choice for the patient in question #3?

A. Not at all confident B. Somewhat confident C. Confident D. Highly confident

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. ) What percentage of the ~40,000 total new HIV infection diagnoses in 2015 occurred in persons aged 50 and older?

2. ) Which of the following antiretroviral treatment regimens is considered to be a “Recommended Initial Regimen for Most People with HIV” by the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents?

3. ) A person is newly-diagnosed with HIV infection. He is determined to be POSITIVE for the HLA-B*5701 major histocompatibility complex (MHC) class I allele. Which of the following antiretrovirals should NOT be administered to the patient?

4. ) TRUE or FALSE: Tenofovir alafenamide should be used instead of tenofovir disoproxil in a patient with a medical comorbidity history that includes osteoporosis.

5. ) Which of the following antiretrovirals would have the LOWEST risk of having CYP450-mediated drug-drug interactions?

6. ) With regard to adherence to the continuum of HIV care, what percentage of patients living with HIV are retained in HIV medical care?

7. ) Which of the following roles could a Pharmacist readily perform in any practice setting as part of a multidisciplinary care team for persons living with HIV?

Evaluation Questions

8. How confident are you in your treatment choice for the patient in question #3?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. ) What percentage of the ~40,000 total new HIV infection diagnoses in 2015 occurred in persons aged 50 and older?

2. ) Which of the following antiretroviral treatment regimens is considered to be a “Recommended Initial Regimen for Most People with HIV” by the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents?

3. ) A person is newly-diagnosed with HIV infection. He is determined to be POSITIVE for the HLA-B*5701 major histocompatibility complex (MHC) class I allele. Which of the following antiretrovirals should NOT be administered to the patient?

4. ) TRUE or FALSE: Tenofovir alafenamide should be used instead of tenofovir disoproxil in a patient with a medical comorbidity history that includes osteoporosis.

5. ) Which of the following antiretrovirals would have the LOWEST risk of having CYP450-mediated drug-drug interactions?

6. ) With regard to adherence to the continuum of HIV care, what percentage of patients living with HIV are retained in HIV medical care?

7. ) Which of the following roles could a Pharmacist readily perform in any practice setting as part of a multidisciplinary care team for persons living with HIV?

Evaluation Questions

8. How confident are you in your treatment choice for the patient in question #3?

« Return to Activity

Customers who Purchased
this Activity also Purchased